Oramed Pharmaceuticals Inc.

ORMP | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.70

-$0.04 (-0.84%)

At close: Sep 21, 2026, 4:00 PM ET

$4.71

+$0.01 (+0.21%)

After-hours: Sep 21, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.84%

(1D)

Rating

Updated: Aug 11, 2026

43.5

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $192.35M

1D Range

4.67 4.74

52W Range

2.09 5.47

Valuation (TTM)

PE 1.14

PB 0.61

EV/EBITDA 1.06

Valuation (NTM)

Forward PE N/A

Forward PEG -0.01

Price Target N/A

Cash Flow

FCF Yield -2.8%

SBC Adj. FCF Yield -4.7%

SBC Impact -68.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y 0.0% | -41.2%

Dil EPS 3Y | 5Y 135.0% | 198.8%

FCF 3Y | 5Y -26.7% | 37.2%

Returns

ROA 47.3%

ROE 73.0%

ROIC -3.2%

Financial Health

Net Cash

$15.36M

Current Ratio 4.98

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally inge...

Sector Healthcare

Industry Biotechnology

Employees 13

IPO Date Apr 30, 2007

Website www.oramed.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.